
						
							
						
						
							<!--
							google_ad_client = "pub-5806585833518451";
							/* 300x250, created 6/2/09 - iposol_ipo_detail_top */
							google_ad_slot = "4379562531";
							google_ad_width = 300;
							google_ad_height = 250;
									-->
							
							
							
						

						Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company.  Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.Claris's product range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology.Companies more than half of the sales come from international markets and have a strong presence in regions of Latin America, the Middle East, Africa and Central, South East and Far East Asia.Claris's manufacturing facilities are located in Ahmedabad, India and approved by foreign regulatory authorities. The manufacturing facilities are ISO 9001-2000 and WHO GMP certified.

						
						
							
						
						

						Company Promoters:The promoters of the company are:1. Mr. Arjun S. Handa2. Sarjan Financial Private Limited

						Company Financials:
   ParticularsFor the year/period ended (in Rs. million)
   31-Dec-0931-Dec-0831-Dec-0731-Dec-0631-Dec-05
     Total Income7,594.017,639.006,238.164,026.742,923.61
     Profit After Tax (PAT)1,303.801,083.95832.72466.93179.30
  

						
							<!--
								google_ad_client = "pub-5806585833518451";
								/* 300x250, created 9/3/09 - IPO Detail Center */
								google_ad_slot = "7910498455";
								google_ad_width = 300;
								google_ad_height = 250;
								-->
							
							
							
						

						Objects of the Issue:The objects of the issue are:1. Setting up of a new plant comprising a small volume parenterals line, a PVC bag line, a non-PVC bag line and a fat emulsion line.2. Setting up of a new manufacturing line for propofol and other fat emulsion products at our existing plant, Clarion IV.3. Construction of a facility for research and development at our Clarion manufacturing facilities.4. Prepayment of an identified term loan.5. General corporate purposes.

						Issue Detail:
						  »»  Issue Open: Nov 24, 2010 - Dec 2, 2010
							  »»  Issue Type: Book Built Issue IPO
							  »»  Issue Size: 12,632,477 Equity Shares of Rs 10 aggregating up to Rs 300.00 Cr
							
							
							  »»  Face Value: Rs 10 Per Equity Share
							  »»  Issue Price: Rs. 228 - Rs. 235 Per Equity Share
							  »»  Market Lot: 22 Shares
							  »»  Minimum Order Quantity: 22 Shares
							  »»  Listing At: BSE
						

						Maximum Subscription Amount for Retail Investor: Rs. 2,00,000

Claris Lifesciences Ltd IPO Grading / Rating
Fitch Ratings India Private Limited has assigned an IPO Grade 3 to Claris Lifesciences Ltd IPO. This means as per Fitch, company has 'Average Fundamentals'. Fitch assigns IPO grading on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals.Click here to download the Fitch IPO Grading Document for Claris Lifesciences Ltd.
Check IPO Ratings from other stock analysts.

Claris Lifesciences Limited IPO Tags:
Claris Lifesciences IPO, Claris IPO, Claris Lifesciences Ltd IPO Bidding, Claris Life IPO Allotment Status, Claris IPO drhp and Claris IPO listing.


						


						
							IPO NoticesClaris Lifesciences IPO revised issue closing date and issue price
 Friday, November 26, 2010
Book Running Lead Manager to the issue has informed the Exchange that the CLARIS LIFESCIENCES LIMITED issue will close on 2 Dec, 2010 instead of the earlier closing day on 26 Nov, 2010.Post issue modification date has been revised to 3 Dec, 2010 instead of the earlier closing day on 27 Nov, 2010. Further price band has revised from 278/- to Rs. 293/- TO Rs. 228/- to Rs. 235/- per share.
						

						
							Issue Subscription Detail / Current Bidding StatusNumber of Times Issue is Subscribed (BSE + NSE)As on Date & TimeQIBNIIRIITotalShares Offered / Reserved4,572,1521,069,1923,207,5778,848,921Day 1 - Nov 24, 2010 17:00 IST0.00000.00000.07000.0200Day 2 - Nov 25, 2010 17:00 IST0.00000.01000.26000.0900Day 3 - Nov 26, 2010 17:00 IST0.15000.10001.22000.4400Day 4 - Nov 29, 2010 17:00 IST0.11000.06001.01000.4200Day 5 - Nov 30, 2010 17:00 IST0.11000.11001.02000.4300Day 6 - Dec 1, 2010 17:00 IST0.11000.30001.06000.47000.4700Day 7 - Dec 2, 2010 17:00 IST1.31002.03001.60001.5000
						
					
